Medikabazaar on track to achieve Rs 3,000-crore mark in FY27: MD and group CEO
B2B healthcare supply chain platform Medikabazaar has posted a 57 per cent growth in the topline to Rs 592 crore in the first quarter of 2026-27, a top company official said on Monday.
The company is firmly on track to achieve a Rs 3,000 crore topline in FY 2026-27, representing approximately 45% growth over the previous financial year, Medikabazaar managing director & group CEO Dinesh Lodha said in a statement.
